Quick Answer
CalciMedica, Inc. reported Diluted EPS of $1.97 per share (loss) for fiscal year 2025.
CalciMedica, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.97 | -61.5% |
| 2024 | -$1.22 | +84.1% |
| 2023 | -$7.66 | +93.1% |
| 2022 | -$111.16 | -6477.5% |
| 2021 | -$1.69 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.52 | -4.0% | -30.0% |
| June 30, 2025 | -$0.40 | -11.1% | -11.1% |
| March 31, 2025 | -$0.36 | -3700.0% | +28.0% |
| September 30, 2024 | -$0.50 | +39.0% | -38.9% |
| June 30, 2024 | -$0.36 | +67.6% | -3700.0% |
| March 31, 2024 | $0.01 | +100.0% | +101.2% |
| September 30, 2023 | -$0.82 | +97.4% | +26.1% |
| June 30, 2023 | -$1.11 | +97.0% | +95.3% |
- CalciMedica, Inc. showed a decrease of -61.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, CalciMedica, Inc.’s diluted eps has declined by 16.6% (from $1.69 per share (loss) to $1.97 per share (loss)).
- The most recent figure is from CalciMedica, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: